1. Neuroprotective effects of melatonin on erectile dysfunction in streptozotocin-induced diabetic rats
    Jiang-lei Zhang et al, 2018, Int Urol Nephrol CrossRef
  2. Gene Expression Profiling of the Sciatic Nerve in Streptozotocin-Induced Diabetic Rats with Peripheral Neuropathy
    Yiji Tu et al, 2020, Journal of Diabetes Research CrossRef
  3. Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption
    Hideki Kitaura et al, 2021, IJMS CrossRef
  4. Teneligliptin Exerts Antinociceptive Effects in Rat Model of Partial Sciatic Nerve Transection Induced Neuropathic Pain
    Yaswanth Kuthati et al, 2021, Antioxidants CrossRef
  5. Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Reinstatement of Cocaine-Mediated Conditioned Place Preference in Mice
    Changliang Zhu et al, 2022, Front. Behav. Neurosci. CrossRef
  6. Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions
    Keshav Mehta et al, 2021, CPPS CrossRef
  7. Glycyrrhizin acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity
    Min Shi et al, 2022, J Biomed Res CrossRef
  8. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
    Jeremy Chung Bo Chiang et al, 2022, Pharmaceuticals CrossRef
  9. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway
    Mingzhu Li et al, 2022, Aging CrossRef
  10. Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies
    Kazunori Sango et al, 2022, Front. Cell Dev. Biol. CrossRef
  11. Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells’ Inflammation and Dysfunction
    Edy Kornelius et al, 2022, Biomolecules CrossRef
  12. Advances in the Pathogenesis and Treatment of MCP-1 in Diabetic Complications
    珏 王, 2022, ACM CrossRef
  13. GLP-1 receptor agonist as a modulator of innate immunity
    Jun Chen et al, 2022, Front. Immunol. CrossRef
  14. Research Progress in the Treatment of Diabetic Peripheral Neuropathy with Traditional Chinese Medicine
    星月 何, 2023, ACM CrossRef
  15. Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
    Chunyan Liu et al, 2024, Front. Endocrinol. CrossRef
  16. Dietary Zn proteinate with moderate chelation strength alleviates heat stress-induced intestinal barrier function damage by promoting expression of tight junction proteins via the A20/NF-κB p65/MMP-2 pathway in the jejunum of broilers
    Yangyang Hu et al, 2024, J Animal Sci Biotechnol CrossRef
  17. Effect of the glucagon‐like peptide‐1 receptor agonists on diabetic peripheral neuropathy: A meta‐analysis
    Shujin Fan et al, 2024, Journal of Neurochemistry CrossRef